Position in GELS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$11,017
New position
Shares Held
16,668
first reported quarter
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $5,995,440 across 11 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
45,162 | $1,565,766 | |
| 2 | ZTS |
Zoetis Inc.
|
14,568 | $1,046,856 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
57,998 | $1,003,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,388 | $752,060 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,399 | $623,358 | |
| 6 | VTRS |
Viatris Inc
|
35,520 | $564,057 | |
| 7 | HLN |
Haleon plc
|
29,818 | $278,201 | |
| 8 | CRON |
Cronos Group Inc.
|
29,697 | $82,557 |
All Filings in GELS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,017 | 16,668 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||